SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc. is trending strongly amid reports of a substantial $1.6 billion investment from the US government for a 10% equity stake, alongside additional private financing. The community is highly bullish, viewing this as a pivotal move to secure domestic rare earth supply chains for national security and defense, with many anticipating a significant price surge and potential short squeeze. This development has fueled broader optimism across the critical minerals sector, highlighting its strategic importance.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing intense interest following a publicized deal with Valio Technologies and Nelson Mandela University, positioning it as a key AI-themed microcap. Community chatter is heavily focused on a potential short squeeze, citing high short interest and a notably low float that is reportedly causing considerable pressure for bearish positions. The stock is drawing comparisons to other significant market movers.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is actively trending as its dedicated community emphasizes its unique multi-chain presence across Solana, BNB, Cronos, and Ethereum (Base), powered by Layerzero technology. Investors are highlighting its deflationary burn mechanism and organic, cult-like following as key differentiators within the meme coin sector.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is trending due to significant community discussion and anticipation following the FDA's recent approval of an updated Afrezza label, offering crucial starting dose guidance for patients switching insulin therapies. This update is widely seen as a major catalyst to simplify use and accelerate adoption, with investors actively debating its impact on future sales and broader market penetration for the inhaled insulin. While some express long-term optimism regarding Afrezza's expanded indications and the company's diverse pipeline, others remain cautious given historical performance and ongoing market skepticism.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors eagerly await 3-year functional data for its Duchenne muscular dystrophy gene therapy, ELEVIDYS, from the EMBARK study, set for release on Monday morning. The community is buzzing with speculation about a potential short squeeze and significant undervaluation given high short interest and institutional accumulation. This pivotal data could reshape perceptions of Elevidys' durability and pave the way for broader market acceptance and potential M&A, alongside anticipated readouts for its promising siRNA pipeline.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is trending following its strategic acquisition of a critical minerals flotation facility, a move expected to enhance its integrated operations from mining to producing military-spec antimony. The community is actively discussing strong bullish sentiment, anticipating significant government investment, and views UAMY as undervalued given its current production for the U.S. military, positioning it for substantial growth within the critical minerals sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to strategic initiatives, including a significant acquisition to accelerate its quantum computing roadmap and solidify its role as a key partner for government defense. The community is buzzing about expanded revenue expectations and its positioning in quantum security and defense infrastructure, viewing it as a foundational player while also debating its valuation amidst broader industry events.

Skywater Technology, Inc. is a holding company. It engages in the provision of semiconductor development, manufacturing services, and packaging services. The company was founded on October 3, 2016 and is headquartered in Bloomington, MN.

SkyWater Technology Inc

SkyWater Technology is trending due to widespread reports of an acquisition attempt by IonQ for approximately $1.8 billion, or around $35 per share. Community discussion is focused on the proposed buyout price, with some shareholders expressing disappointment over the perceived lack of a premium while others celebrate the potential exit. This interest underscores SkyWater's strategic importance as a domestic foundry for specialized chips, particularly in quantum computing and defense, aligning with broader national security and reshoring trends.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is actively discussed after the pardon of Binance founder CZ, which the community widely interprets as a significant bullish catalyst for the ecosystem. This development is fueling optimism about BNB's future trajectory, alongside ongoing institutional interest and the platform's expanding offerings like real-world asset tokenization.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending amidst a historic surge in silver prices, which has ignited widespread community excitement and discussions about the company's significant production increases and recent dividend hike. Despite the metal's impressive ascent, many investors believe silver miners like AG remain undervalued, with calls for a substantial revaluation as physical demand outstrips supply and market manipulation is debated. The prevailing sentiment anticipates further upside as the sector prepares for a significant repricing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in Globus Medical, Inc. $GMED

Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 28.9% during the third quarter, according to its most recent Form 13F filing...

Massachusetts Financial Services Co. MA Sells 165,185 Shares of Globus Medical, Inc. $GMED

Massachusetts Financial Services Co. MA lowered its stake in Globus Medical, Inc. (NYSE:GMED - Free Report) by 19.5% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Globus Medical, Inc. (NYSE:GMED) Given Average Recommendation of "Moderate Buy" by Brokerages

Globus Medical, Inc. (NYSE:GMED - Get Free Report) has earned an average recommendation of "Moderate Buy" from the fifteen analysts that are currently covering the firm, MarketBeat Ratings reports...

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Anchor Capital Advisors LLC Purchases 237,331 Shares of Globus Medical, Inc. $GMED

Anchor Capital Advisors LLC raised its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 42.2% in the 3rd quarter, according to the company in its most recent Form 13F filing...

Should You Still Hold GMED Stock in Your Portfolio?

Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.

Stephens Investment Management Group LLC Increases Stock Position in Globus Medical, Inc. $GMED

Stephens Investment Management Group LLC boosted its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 10.7% in the 3rd quarter, according to the company in its most recent 13F filing...

Pembroke Management LTD Sells 38,745 Shares of Globus Medical, Inc. $GMED

Pembroke Management LTD lowered its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 6.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Insider Move: Kyle Kline Exercises Options, Realizing $125K At Globus Medical

Kyle Kline Sells 3,594 Shares of Globus Medical (NYSE:GMED) Stock

Globus Medical, Inc. (NYSE:GMED - Get Free Report) CFO Kyle Kline sold 3,594 shares of the firm's stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Globus Medical Inc - Ordinary Shares - Class A

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$92.52
Prev Close	$94.64
Open	$94.51
Dividend Yield	0.00%
50-Day Moving Average	$88.84
Beta	1.01
Avg. Volume	1.35M
PE Ratio	29.90

52-Week High	$101.40
52-Week Low	$51.79
Market Capitalization	$12.45B
EPS (Annual)	$0.747
Price to Book	2.83
Revenue Per Employee	$475,350.00
Enterprise Value/EBITDA	N/A

GMED
Globus Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GMED News

GMEDGlobus Medical Inc